Abstract
Purpose
The purpose of this study was to assess the impact of positron emission tomography/X-ray computed tomography (PET/CT) acquisition and reconstruction parameters on the assessment of mineralization process in a mouse model of atherosclerosis.
Procedures
All experiments were performed on a dedicated preclinical PET/CT system. CT was evaluated using five acquisition configurations using both a tungsten wire phantom for in-plane resolution assessment and a bar pattern phantom for cross-plane resolution. Furthermore, the radiation dose of these acquisition configurations was calculated. The PET system was assessed using longitudinal line sources to determine the optimal reconstruction parameters by measuring central resolution and its coefficient of variation. An in vivo PET study was performed using uremic ApoE−/−, non-uremic ApoE−/−, and control mice to evaluate optimal PET reconstruction parameters for the detection of sodium [18F]fluoride (Na[18F]F) aortic uptake and for quantitative measurement of Na[18F]F bone influx (Ki) with a Patlak analysis.
Results
For CT, the use of 1 × 1 and 2 × 2 binning detector mode increased both in-plane and cross-plane resolution. However, resolution improvement (163 to 62 μm for in-plane resolution) was associated with an important radiation dose increase (1.67 to 32.78 Gy). With PET, 3D-ordered subset expectation maximization (3D-OSEM) algorithm increased the central resolution compared to filtered back projection (1.42 ± 0.35 mm vs. 1.91 ± 0.08, p < 0.001). The use of 3D-OSEM with eight iterations and a zoom factor 2 yielded optimal PET resolution for preclinical study (FWHM = 0.98 mm). These PET reconstruction parameters allowed the detection of Na[18F]F aortic uptake in 3/14 ApoE−/− mice and demonstrated a decreased Ki in uremic ApoE−/− compared to non-uremic ApoE−/− and control mice (p < 0.006).
Conclusions
Optimizing reconstruction parameters significantly impacted on the assessment of mineralization process in a preclinical model of accelerated atherosclerosis using Na[18F]F PET. In addition, improving the CT resolution was associated with a dramatic radiation dose increase.
Similar content being viewed by others
References
Osborn EA, Jaffer FA (2013) The advancing clinical impact of molecular imaging in CVD. JACC Cardiovasc Imaging 6:1327–1341
Johnson RC, Leopold JA, Loscalzo J (2006) Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99:1044–1059
Jono S, Shioi A, Ikari Y, Nishizawa Y (2006) Vascular calcification in chronic kidney disease. J Bone Miner Metab 24:176–181
Doherty TM, Asotra K, Fitzpatrick LA, Qiao JH, Wilkin DJ, Detrano RC, Dunstan CR, Shah PK, Rajavashisth TB (2003) Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A 100:11201–11206
Fiz F, Morbelli S, Piccardo A, Bauckneht M, Ferrarazzo G, Pestarino E, Cabria M, Democrito A, Riondato M, Villavecchia G, Marini C, Sambuceti G (2015) 18F-NaF uptake by atherosclerotic plaque on PET/CT imaging: inverse correlation between calcification density and mineral metabolic activity. J Nucl Med 56:1019–1023
Derlin T, Richter U, Bannas P, Begemann P, Buchert R, Mester J, Klutmann S (2010) Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med 51:862–865
Dweck MR, Chow MWL, Joshi NV, Williams MC, Jones C, Fletcher AM, Richardson H, White A, McKillop G, van Beek EJR, Boon NA, Rudd JHF, Newby DE (2012) Coronary arterial 18F-sodium fluoride uptake. J Am Coll Cardiol 59:1539–1548
Lasnon C, Dugue AE, Briand M, Blanc-Fournier C, Dutoit S, Louis MH, Aide N (2015) NEMA NU 4-optimized reconstructions for therapy assessment in cancer research with the Inveon small animal PET/CT system. Mol Imaging Biol 17:403–412
Ghani MU, Zhou Z, Ren L, Wong M, Li Y, Zheng B, Yang K, Liu H (2016) Investigation of spatial resolution characteristics of an in vivo microcomputed tomography system. Nucl Instrum Methods Phys Res Sect Accel Spectrometers Detect Assoc Equip 807:129–136
Loening AM, Gambhir SS (2003) AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2:131–137
Massy ZA (2004) Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 16:109–116
Joly L, Djaballah W, Koehl G, Mandry D, Dolivet G, Marie PY, Benetos A (2009) Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification. Eur J Nucl Med Mol Imaging 36:979–985
Willekens I, Lahoutte T, Buls N, Vanhove C, Deklerck R, Bossuyt A, de Mey J (2009) Time-course of contrast enhancement in spleen and liver with Exia 160, Fenestra LC, and VC. Mol Imaging Biol 11:128–135
Badea CT, Hedlund LW, De Lin M et al (2006) Tumor imaging in small animals with a combined micro-CT/micro-DSA system using iodinated conventional and blood pool contrast agents. Contrast Media Mol Imaging 1:153–164
Suckow CE, Stout DB (2008) MicroCT liver contrast agent enhancement over time, dose, and mouse strain. Mol Imaging Biol 10:114–120
Vandeghinste B, Trachet B, Renard M, Casteleyn C, Staelens S, Loeys B, Segers P, Vandenberghe S (2011) Replacing vascular corrosion casting by in vivo micro-CT imaging for building 3D cardiovascular models in mice. Mol Imaging Biol 13:78–86
Joubert M, Tager P, Legallois D, Defourneaux E, le Guellec B, Gerber B, Morello R, Manrique A (2017) Test-retest reproducibility of cardiac magnetic resonance imaging in healthy mice at 7-tesla: effect of anesthetic procedures. Sci Rep 7:6698. https://doi.org/10.1038/s41598-017-07083-1
Ford NL, Thornton MM, Holdsworth DW (2003) Fundamental image quality limits for microcomputed tomography in small animals. Med Phys 30:2869–2877
Bartling SH, Stiller W, Semmler W, Kiessling F (2007) Small animal computed tomography imaging. Curr Med Imaging Rev 3:45–59
Sato F, Sasaki S, Kawashima N, Chino F (1981) Late effects of whole or partial body x-irradiation on mice: life shortening. Int J Radiat Biol Relat Stud Phys Chem Med 39:607–615
Visser EP, Disselhorst JA, Brom M, Laverman P, Gotthardt M, Oyen WJ, Boerman OC (2009) Spatial resolution and sensitivity of the Inveon small-animal PET scanner. J Nucl Med 50:139–147
Chatziioannou A, Qi J, Moore A, Annala A, Nguyen K, Leahy R, Cherry SR (2000) Comparison of 3-D maximum a posteriori and filtered backprojection algorithms for high-resolution animal imaging with microPET. IEEE Trans Med Imaging 19:507–512
Constantinescu CC, Mukherjee J (2009) Performance evaluation of an Inveon PET preclinical scanner. Phys Med Biol 54:2885–2899
Kemp BJ, Hruska CB, McFarland AR et al (2009) NEMA NU 2-2007 performance measurements of the Siemens Inveon™ preclinical small animal PET system. Phys Med Biol 54:2359–2376
Derlin T, Wisotzki C, Richter U, Apostolova I, Bannas P, Weber C, Mester J, Klutmann S (2011) In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET/CT: correlation with atherogenic risk factors. J Nucl Med 52:362–368
Irmler IM, Gebhardt P, Hoffmann B, Opfermann T, Figge MT, Saluz HP, Kamradt T (2014) 18F-fluoride positron emission tomography/computed tomography for noninvasive in vivo quantification of pathophysiological bone metabolism in experimental murine arthritis. Arthritis Res Ther 16:R155
Cheng C, Alt V, Pan L, Thormann U, Schnettler R, Strauss LG, Schumacher M, Gelinsky M, Dimitrakopoulou-Strauss A (2014) Preliminary evaluation of different biomaterials for defect healing in an experimental osteoporotic rat model with dynamic PET-CT (dPET-CT) using F-18-sodium fluoride (NaF). Injury 45:501–505
Rochette L, Meloux A, Rigal E, Zeller M, Cottin Y, Vergely C (2018) The role of osteoprotegerin in the crosstalk between vessels and bone: its potential utility as a marker of cardiometabolic diseases. Pharmacol Ther 182:115–132
Gagnon RF, Duguid WP (1983) A reproducible model for chronic renal failure in the mouse. Urol Res 11:11–14
Piert M, Zittel TT, Becker GA, Jahn M, Stahlschmidt A, Maier G, Machulla HJ, Bares R (2001) Assessment of porcine bone metabolism by dynamic [18F]fluoride ion PET: correlation with bone histomorphometry. J Nucl Med 42:1091–1100
Nikolov IG, Joki N, Nguyen-Khoa T, Ivanovski O, Phan O, Lacour B, Drüeke TB, Massy ZA, dos Reis LM, Jorgetti V, Lafage-Proust MH (2010) Chronic kidney disease bone and mineral disorder (CKD–MBD) in apolipoprotein E-deficient mice with chronic renal failure. Bone 47:156–163
Acknowledgments
This work was conducted as part of the FHU REMOD-VHF project and supported by the French Government, managed by the National Research Agency (ANR) under the program “Investissements d’avenir” with the reference ANR-16-RHUS-0003. The authors want to thank Sebastien Hapdey, PhD, for reviewing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The institutional animal ethics committee approved the animal experiments (#3979).
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Rucher, G., Cameliere, L., Fendri, J. et al. Performance Evaluation of a Dedicated Preclinical PET/CT System for the Assessment of Mineralization Process in a Mouse Model of Atherosclerosis. Mol Imaging Biol 20, 984–992 (2018). https://doi.org/10.1007/s11307-018-1202-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-018-1202-2